Newsletter
Every new paper in this field, in your inbox.
Following bariatric surgery, patients with gout benefited from uric acid-lowering medication, exhibiting reduced gout attacks and serum uric acid levels. Patients who continued medication showed fewer gout attacks and decreased serum uric acid levels after 6 months, compared to those who did not receive treatment.…
Metabolic and bariatric surgery (MBS) is effective for sustained weight loss in chronic kidney disease (CKD) patients, with acceptable complication rates. Roux-en-Y gastric bypass (RYGB) leads to higher weight loss percentages but carries a higher risk of late surgical complications compared to sleeve gastrectomy (SG).…
Study shows laparoscopic exploration with a disposable bronchoscope is safe and effective for removing common bile duct stones in gastric bypass patients, achieving 100% stone clearance without conversions to open surgery. This cost-effective approach offers a practical alternative to traditional methods, demonstrating feasibility and safety…
In minimally invasive upper gastrointestinal and bariatric surgery, a trocar-less elastic intra-corporeal retractor (icr) was developed and proven effective in liver retraction. The icr is safe, inexpensive, and easily reproducible, reducing risks of bleeding, infection, and liver injury associated with conventional methods. It offers quick…
Metabolic surgery significantly reduces kidney impairment progression and lowers the risk of kidney failure or death by 60% and 44%, respectively, when compared to GLP-1 receptor agonists in patients with type 2 diabetes, obesity, and established chronic kidney disease. This highlights the potential of metabolic…
Aprepitant significantly reduces postoperative nausea and vomiting in patients undergoing metabolic bariatric surgery, improving recovery and patient satisfaction. Meta-analysis of six studies involving 929 patients showed a significant decrease in ponv incidence with aprepitant, particularly at 0, 6, and 12 hours postoperatively. Administering aprepitant within…
Early body-weight loss (< 37.7% EBWL) at 3 months post-laparoscopic sleeve gastrectomy predicts poorer long-term weight loss outcomes. High BMI, elevated neutrophil-to-lymphocyte ratio (≥ 2.36), and female sex are significant risk factors for suboptimal weight loss. These findings highlight the potential utility of targeted interventions…
Conversion from Sleeve Gastrectomy to Roux-en-Y Gastric Bypass significantly reduced GERD symptoms and PPI use, with 70% of patients experiencing complete symptom resolution and 60% discontinuing PPIs. This approach led to improved postoperative outcomes, decreasing daily symptoms of GERD and the need for PPIs. The…
Study reveals a non-linear, inverted U-shaped association between preoperative BMI and optimal weight loss outcomes post bariatric surgery. Setting a BMI threshold of 42.9 is critical in predicting optimal clinical responses in patients with obesity. Quartile odds ratios and restricted cubic spline analysis support this…
One-anastomosis gastric bypass (OAGB) and Roux-en-Y gastric bypass (RYGB) showed similar improvements in renal function one year post-surgery, with OAGB leading to greater weight loss. Both procedures resulted in significantly higher estimated glomerular filtration rates. Younger age and lower baseline renal function were associated with…
